Skip to main content
PMC home page
Annals of the Rheumatic Diseases logoLink to Annals of the Rheumatic Diseases
. 2002 Feb;61(2):97–99. doi: 10.1136/ard.61.2.97

Atherosclerosis

Y Sherer 1, Y Shoenfeld 1
PMCID: PMC1753999  PMID: 11796391

Full Text

The Full Text of this article is available as a PDF (119.3 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Afek A., George J., Shoenfeld Y., Gilburd B., Levy Y., Shaish A., Keren P., Janackovic Z., Goldberg I., Kopolovic J. Enhancement of atherosclerosis in beta-2-glycoprotein I-immunized apolipoprotein E-deficient mice. Pathobiology. 1999;67(1):19–25. doi: 10.1159/000028046. [DOI] [PubMed] [Google Scholar]
  2. Ameli S., Hultgårdh-Nilsson A., Regnström J., Calara F., Yano J., Cercek B., Shah P. K., Nilsson J. Effect of immunization with homologous LDL and oxidized LDL on early atherosclerosis in hypercholesterolemic rabbits. Arterioscler Thromb Vasc Biol. 1996 Aug;16(8):1074–1079. doi: 10.1161/01.atv.16.8.1074. [DOI] [PubMed] [Google Scholar]
  3. Bergmark C., Wu R., de Faire U., Lefvert A. K., Swedenborg J. Patients with early-onset peripheral vascular disease have increased levels of autoantibodies against oxidized LDL. Arterioscler Thromb Vasc Biol. 1995 Apr;15(4):441–445. doi: 10.1161/01.atv.15.4.441. [DOI] [PubMed] [Google Scholar]
  4. Bui M. N., Sack M. N., Moutsatsos G., Lu D. Y., Katz P., McCown R., Breall J. A., Rackley C. E. Autoantibody titers to oxidized low-density lipoprotein in patients with coronary atherosclerosis. Am Heart J. 1996 Apr;131(4):663–667. doi: 10.1016/s0002-8703(96)90268-9. [DOI] [PubMed] [Google Scholar]
  5. Cherubini A., Mecocci P., Senin U., Lowenthal D. T., Barnert G., Chionne F. Autoantibodies against oxidized low-density lipoproteins in older stroke patients. J Am Geriatr Soc. 1997 Jan;45(1):125–125. doi: 10.1111/j.1532-5415.1997.tb01001.x. [DOI] [PubMed] [Google Scholar]
  6. Emeson E. E., Shen M. L., Bell C. G., Qureshi A. Inhibition of atherosclerosis in CD4 T-cell-ablated and nude (nu/nu) C57BL/6 hyperlipidemic mice. Am J Pathol. 1996 Aug;149(2):675–685. [PMC free article] [PubMed] [Google Scholar]
  7. George J., Afek A., Gilburd B., Blank M., Levy Y., Aron-Maor A., Levkovitz H., Shaish A., Goldberg I., Kopolovic J. Induction of early atherosclerosis in LDL-receptor-deficient mice immunized with beta2-glycoprotein I. Circulation. 1998 Sep 15;98(11):1108–1115. doi: 10.1161/01.cir.98.11.1108. [DOI] [PubMed] [Google Scholar]
  8. George J., Afek A., Gilburd B., Levkovitz H., Shaish A., Goldberg I., Kopolovic Y., Wick G., Shoenfeld Y., Harats D. Hyperimmunization of apo-E-deficient mice with homologous malondialdehyde low-density lipoprotein suppresses early atherogenesis. Atherosclerosis. 1998 May;138(1):147–152. doi: 10.1016/s0021-9150(98)00015-x. [DOI] [PubMed] [Google Scholar]
  9. George J., Afek A., Gilburd B., Levy Y., Blank M., Kopolovic J., Harats D., Shoenfeld Y. Atherosclerosis in LDL-receptor knockout mice is accelerated by immunization with anticardiolipin antibodies. Lupus. 1997;6(9):723–729. [PubMed] [Google Scholar]
  10. George J., Afek A., Gilburd B., Shoenfeld Y., Harats D. Cellular and humoral immune responses to heat shock protein 65 are both involved in promoting fatty-streak formation in LDL-receptor deficient mice. J Am Coll Cardiol. 2001 Sep;38(3):900–905. doi: 10.1016/s0735-1097(01)01440-1. [DOI] [PubMed] [Google Scholar]
  11. George J., Harats D., Gilburd B., Afek A., Shaish A., Kopolovic J., Shoenfeld Y. Adoptive transfer of beta(2)-glycoprotein I-reactive lymphocytes enhances early atherosclerosis in LDL receptor-deficient mice. Circulation. 2000 Oct 10;102(15):1822–1827. doi: 10.1161/01.cir.102.15.1822. [DOI] [PubMed] [Google Scholar]
  12. George J., Shoenfeld Y., Afek A., Gilburd B., Keren P., Shaish A., Kopolovic J., Wick G., Harats D. Enhanced fatty streak formation in C57BL/6J mice by immunization with heat shock protein-65. Arterioscler Thromb Vasc Biol. 1999 Mar;19(3):505–510. doi: 10.1161/01.atv.19.3.505. [DOI] [PubMed] [Google Scholar]
  13. George J., Shoenfeld Y., Gilburd B., Afek A., Shaish A., Harats D. Requisite role for interleukin-4 in the acceleration of fatty streaks induced by heat shock protein 65 or Mycobacterium tuberculosis. Circ Res. 2000 Jun 23;86(12):1203–1210. doi: 10.1161/01.res.86.12.1203. [DOI] [PubMed] [Google Scholar]
  14. Grainger D. J., Bethell H. W. L. High titres of serum antinuclear antibodies, mostly directed against nucleolar antigens, are associated with the presence of coronary atherosclerosis. Ann Rheum Dis. 2002 Feb;61(2):110–114. doi: 10.1136/ard.61.2.110. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Laurat E., Poirier B., Tupin E., Caligiuri G., Hansson G. K., Bariéty J., Nicoletti A. In vivo downregulation of T helper cell 1 immune responses reduces atherogenesis in apolipoprotein E-knockout mice. Circulation. 2001 Jul 10;104(2):197–202. doi: 10.1161/01.cir.104.2.197. [DOI] [PubMed] [Google Scholar]
  16. Lehtimäki T., Lehtinen S., Solakivi T., Nikkilä M., Jaakkola O., Jokela H., Ylä-Herttuala S., Luoma J. S., Koivula T., Nikkari T. Autoantibodies against oxidized low density lipoprotein in patients with angiographically verified coronary artery disease. Arterioscler Thromb Vasc Biol. 1999 Jan;19(1):23–27. doi: 10.1161/01.atv.19.1.23. [DOI] [PubMed] [Google Scholar]
  17. Maggi E., Chiesa R., Melissano G., Castellano R., Astore D., Grossi A., Finardi G., Bellomo G. LDL oxidation in patients with severe carotid atherosclerosis. A study of in vitro and in vivo oxidation markers. Arterioscler Thromb. 1994 Dec;14(12):1892–1899. doi: 10.1161/01.atv.14.12.1892. [DOI] [PubMed] [Google Scholar]
  18. Moulias R., Proust J., Wang A., Congy F., Marescot M. R., Deville Chabrolle A., Paris Hamelin A., Lesourd B. Age-related increase in autoantibodies. Lancet. 1984 May 19;1(8386):1128–1129. doi: 10.1016/s0140-6736(84)92547-9. [DOI] [PubMed] [Google Scholar]
  19. Salonen J. T., Ylä-Herttuala S., Yamamoto R., Butler S., Korpela H., Salonen R., Nyyssönen K., Palinski W., Witztum J. L. Autoantibody against oxidised LDL and progression of carotid atherosclerosis. Lancet. 1992 Apr 11;339(8798):883–887. doi: 10.1016/0140-6736(92)90926-t. [DOI] [PubMed] [Google Scholar]
  20. Sherer Y., Shemesh J., Tenenbaum A., Praprotnik S., Harats D., Fisman E. Z., Blank M., Motro M., Shoenfeld Y. Coronary calcium and anti-cardiolipin antibody are elevated in patients with typical chest pain. Am J Cardiol. 2000 Dec 15;86(12):1306–1311. doi: 10.1016/s0002-9149(00)01232-7. [DOI] [PubMed] [Google Scholar]
  21. Sherer Y., Shoenfeld Y. Antiphospholipid syndrome, antiphospholipid antibodies, and atherosclerosis. Curr Atheroscler Rep. 2001 Jul;3(4):328–333. doi: 10.1007/s11883-001-0027-6. [DOI] [PubMed] [Google Scholar]
  22. Sherer Y., Tenenbaum A., Praprotnik S., Shemesh J., Blank M., Fisman E. Z., Harats D., George J., Levy Y., Peter J. B. Coronary artery disease but not coronary calcification is associated with elevated levels of cardiolipin, beta-2-glycoprotein-I, and oxidized LDL antibodies. Cardiology. 2001;95(1):20–24. doi: 10.1159/000047338. [DOI] [PubMed] [Google Scholar]
  23. Shoenfeld Y., Sherer Y., George J., Harats D. Autoantibodies associated with atherosclerosis. Ann Med. 2000 Dec;32 (Suppl 1):37–40. [PubMed] [Google Scholar]
  24. Shoenfeld Y., Sherer Y., George Y., Harats D. beta 2-glycoprotein I in human and murine atherosclerosis. Isr Med Assoc J. 2001 Feb;3(2):85–87. [PubMed] [Google Scholar]
  25. Shoenfeld Y., Sherer Y., Harats D. Artherosclerosis as an infectious, inflammatory and autoimmune disease. Trends Immunol. 2001 Jun;22(6):293–295. doi: 10.1016/s1471-4906(01)01922-6. [DOI] [PubMed] [Google Scholar]
  26. Vaarala O., Mänttäri M., Manninen V., Tenkanen L., Puurunen M., Aho K., Palosuo T. Anti-cardiolipin antibodies and risk of myocardial infarction in a prospective cohort of middle-aged men. Circulation. 1995 Jan 1;91(1):23–27. doi: 10.1161/01.cir.91.1.23. [DOI] [PubMed] [Google Scholar]
  27. Wu R., Nityanand S., Berglund L., Lithell H., Holm G., Lefvert A. K. Antibodies against cardiolipin and oxidatively modified LDL in 50-year-old men predict myocardial infarction. Arterioscler Thromb Vasc Biol. 1997 Nov;17(11):3159–3163. doi: 10.1161/01.atv.17.11.3159. [DOI] [PubMed] [Google Scholar]
  28. Xu Q., Dietrich H., Steiner H. J., Gown A. M., Schoel B., Mikuz G., Kaufmann S. H., Wick G. Induction of arteriosclerosis in normocholesterolemic rabbits by immunization with heat shock protein 65. Arterioscler Thromb. 1992 Jul;12(7):789–799. doi: 10.1161/01.atv.12.7.789. [DOI] [PubMed] [Google Scholar]
  29. Xu Q., Willeit J., Marosi M., Kleindienst R., Oberhollenzer F., Kiechl S., Stulnig T., Luef G., Wick G. Association of serum antibodies to heat-shock protein 65 with carotid atherosclerosis. Lancet. 1993 Jan 30;341(8840):255–259. doi: 10.1016/0140-6736(93)92613-x. [DOI] [PubMed] [Google Scholar]

Articles from Annals of the Rheumatic Diseases are provided here courtesy of BMJ Publishing Group

RESOURCES